Advancing the Optimal Dosing of Oncology Therapies Using Predictive Tumour Models
- Highlighting the rationale behind selecting the model
- Identifying predictive biomarkers that correlate with drug response, aiding in patient stratification and personalised treatment
- Leveraging findings to empower dosing strategies and spotlighting future directions